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A B S T R A C T
Circulating tumor cells (CTCs) are rare cancer cells, which originate from the primary tumors and migrate to the bloodstream. Separation of CTCs from blood is
critical because metastatic CTCs might hold diﬀerent genomic and phenotypic properties compared to primary tumor cells. In this regard, accurate prognosis and
eﬀective treatment methods are necessary. For this purpose, focusing biological particles and cells using microﬂuidic systems have been implemented as an eﬃcient
CTCs enumeration and enrichment method. Passive, continuous, label-free and parallelizable size-dependent focusing based on hydrodynamic forces is preferred in
this study to sort cancer cells while avoiding cell death and achieving high throughput. The focusing behavior of MDA-MB-231 (11–22 μm), Jurkat (8–17 μm), K562
(8–22 μm), and HeLa (16–29 μm) was examined with respect to diﬀerent Reynolds numbers and Dean numbers. The eﬀect of curvature on cell focusing was carefully
assessed. The focusing positions of the cells clearly indicated that isolations of MDA cells from MDA-Jurkat cell mixtures as well as of HeLa cells from HeLa-Jurkat cell
mixtures were possible by using the curvilinear channels with a curvature angle of 280° at the Reynolds number of 121.
1. Introduction
Metastatic tumors originate from primary tumors and are spread
through the lymphatic system or bloodstream to the other parts of the
body. Due to some genetic mutations, millions of cells shelter in pri-
mary tumors and accomplish maintaining cellular functions such as
proliferation. Owing to uncontrolled continuous cell proliferation, pri-
mary tumor forms, and some rare cells from this tumor become invasive
and are released from the primary tumor and start to circulate through
to the bloodstream. Most of these cells so-called “circulating tumor cells
(CTCs)” die during circulation in the bloodstream, while only 0.01% of
them will likely lead to metastasis [1]. While primary tumors barely
cause cancer deaths, metastatic cancers ultimately account for 90% of
mortality [2]. Thus, development of isolation or detection methods for
CTCs will play an important role in assisting oncologists to accurately
interpret cancer characteristics while enhancing eﬀective treatment
strategies.
Conventional diagnostic strategies for primary tumors include
cancer type and cancer location based evaluation of clinical symptoms
and rely on imaging techniques such as Magnetic Resonance Imaging
(MRI), Computed Tomography (CT), Magnetic Resonance Spectroscopy
(MRS), Positron Emission Tomography (PET), Radiography (X-ray),
ultrasonography and tissue biopsy examination under microscope [3].
These techniques are based on the utilization of biomarkers identiﬁed
from genomic or proteomic analysis and are able to provide morpho-
logical, structural, metabolic and functional information about the tu-
mors [4]. However, these techniques can be used only if the tumor is
achieved to a certain size and cannot be applied to identify the presence
of tumor in early stages, its aggressiveness as well as its response to
therapy. Moreover, even though microscopic evaluation of biopsy ma-
terial by immunohistochemical staining is able to conﬁrm the origin of
cancer, there is a clinical suspicion that cancer may not come directly
from the biopsy site. Furthermore, the evaluation of molecular bio-
markers is usually performed by using primary tumor tissues but this
approach does not take potential diversity and heterogeneity between
primary tumor and metastatic lesions into account [5]. Thus, primary
tumor sampling cannot oﬀer suﬃcient information about prognosis and
treatment [6]. These problems could be solved using a new diagnostic
concept: liquid biopsy requiring isolation of CTCs or cell-free circu-
lating tumor DNA (catena) from blood [7]. The detection of CTCs in the
peripheral blood of patients with cancer is increasingly investigated as a
novel biomarker of tumor's growth dynamics, having the potential to
give prognostic information and to predict response to chemotherapy
[8].
Besides the fact that CTCs may shed light on the evaluation of the
cancer stage and determination of therapeutic techniques, CTCs could
possibly provide real-time monitoring of tumor progression as re-
presentative biomarkers. Metastatic CTCs may have diﬀerent genomic
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and phenotypic information in comparison to primary tumor cells or
other CTCs as a result of secondary mutation so-called tumor hetero-
geneity, which constitutes a signiﬁcant debate in the literature [9–11].
Molecular and cellular analysis of CTCs could contribute to novel per-
sonalized cancer treatments [7,12]. However, the concentration of
CTCs was estimated to be 1 to 10 CTCs per 107–109 blood cells [13].
Hence, achieving pure CTCs from the blood is still challenging.
Microﬂuidic technologies come into play with many advantages
over conventional technologies such as the requirement of small sample
volume, low-cost production and processing higher sensitivity and
improved performance [14,15]. Furthermore, microﬂuidic technologies
also facilitate fabrication of integrative, portable point of care diag-
nostics devices based on lab on a chip or micro-total-analysis-systems
(μTAS). From the microﬂuidics point of view, separation principles can
be divided into two categories depending on external energy usage:
active and passive separation [16]. While active techniques require
external forces such as magnetic [17], dielectric [18], and acoustic [19]
to separate particles/cells, passive techniques utilize mainly hydro-
dynamic forces [20]. Passive techniques can be further separated into
ﬁltration based, deterministic lateral displacement based and inertia-
based ones [21]. Noticeably, active techniques provide more accurate
results yet are limited by the low throughput, integration of complex
components and expensive production or process requirements. Several
recent microﬂuidics cell sorting/isolation reviews can be found in the
literature to better understand separation characteristics and physics
[22–34].
Liquid biopsy requires isolation of CTCs from the blood followed by
single cell analysis. Among the various CTC isolation methods, inertial
microﬂuidics is one of the most appealing size-based isolation phe-
nomena particularly because of its high throughput, easy-to-operate
and cheaper nature. However, as the other size-based methods, the
main deﬁciency of the inertial microﬂuidics is low purity because of the
size overlapping of the blood cells and CTCs. At this point, under-
standing the physics behind the focusing behavior of cells is critical to
be able to design novel microchannels to increase the isolation eﬃ-
ciency and purity of CTCs. Recently, the behavior of rigid particles,
cancer cells, CTCs or blood cells as well as isolation eﬃciency of dif-
ferent cell types or particles have been investigated using various types
of channel geometries including straight [35–37], spiral [38–42], ser-
pentine [43–48], and straight channel with contraction-expansion ar-
rays [49–51] in inertial microﬂuidics. However, focusing behavior of
the cancer cells in a serpentine channel has not attracted as much at-
tention as the other types.
In this study, continuous, high throughput, label-free and paralle-
lizable size-based cell sorting was performed in symmetrically curved
channels by taking the advantage of inertial microﬂuidics and Dean
ﬂow physics while avoiding cell death or damage. The purpose is to
understand the curvature eﬀect as well as to achieve an eﬃcient cell
focusing in the curvilinear microchannels. Cell focusing behavior for
human cancer subtypes from cell lines with diverse biological and
biophysical properties was assessed at diﬀerent ﬂow rates by taking the
cell viability and average size of the cells into consideration. The forces
acting on these human cancer cell lines alter depending on their 3D
location, yet, the concomitant eﬀect is still unknown. After the de-
termination of the optimum parameters to enrich the circulating tumor
cell lines, focusing behavior of MDA-MB-231, Jurkat, K562, and HeLa
were examined in detail at various Reynolds numbers and Dean num-
bers. This study has the potential to provide a contribution to the lit-
erature in this regard. The assessment of cancer cell migration and
equilibrium positions of these cells will lead to the design of futuristic
microﬂuidic innovations for precise detection and diagnosis of cancer in
point of care devices with lower costs.
2. Method
2.1. COMSOL modelling
For analyzing the ﬂuid ﬂow inside the microchannel, and acquiring
the cross-sectional velocity proﬁles, COMSOL Multiphysics 5.2 software
(COMSOL Inc., Burlington, MA) was used in this study (For the details,
see Supp. Info, Text-S2).
2.2. Device fabrication
The PDMS (polydimethylsiloxane) microchannels were fabricated
by using the standard soft lithography technique based on our previous
study [52]. The details of the technique can be found in Supp. Info.,
Text S3.
2.3. Cell culture/sample preparation and viability assay
Human breast adenocarcinoma cell line MDA-MB-231 (11–22 μm),
human acute T lymphocyte leukemia cell line Jurkat (8–17 μm), human
chronic myelogenous leukemia cell line K562 (8–22 μm), and human
cervix adenocarcinoma cell line HeLa (16–29 μm) were used in this
study. MDA-MB-231 and HeLa cells were maintained in DMEM high
glucose medium (PAN Biotech, P04–03500); Jurkat and K562 cells
were maintained in RPMI 1640 medium (Gibson, 31,870–025) in a 5%
CO2-humidiﬁed incubator at 37 °C. Culture media were supplemented
with 10% heat-inactivated fetal bovine serum (Biowest, S1810–500),
antibiotics (50 units/mL penicillin and 50 g/mL streptomycin; Gibco,
15,140–122), and L-glutamine (2mM, Gibco, 25,030–024).
Additionally, MDA-MB-231 media was supplemented with 1× non-
essential amino acids MEM-NEAA solution (Gibco,11,140,035). The
cells were split in every 2 days. Since MDA-MB-231 and HeLa cells are
adherent cell lines, Trypsin EDTA Solution A, 0.25%–0.02% (Biological
Industries, BI03–050-1A) was used to detach cells. 1/10 of the detached
cells were inoculated in fresh media. Jurkat and K562 are suspension
cell lines. Therefore, 1/10 of their total culture were directly inoculated
to fresh media without trypsin treatment.
The cells were ﬂuorescently stained by using DILC18(3) (Life
Technologies, D3911). Stock dye solution (2.5 mg/mL) was prepared in
Dimethyl Sulfoxide (DMSO) (Santa Cruz, cs-358,801). The cells were re-
suspended in PBS (Gibco, 20,012–019) containing 3% FBS in 1,000,000
cells/mL concentration. Stock dye was added in a ratio of 5 μL/mL of
the cell suspension. HeLa, MDA-MB-231, and K562 cell lines were in-
cubated with the dye for 20min, while Jurkat cell line was incubated
for 5min at 37 °C. Then, the cells were washed with 1mL PBS at least
for 10 times until the supernatant became completely clear. The ﬁnal
number of the cells was adjusted to 150,000 cells/mL by resuspending
them in PBS containing 3% FBS. Lastly, the whole suspension was ﬁl-
tered through 70 μm cell strainer (Falcon, 352,350) prior to its injection
to the chip system.
The morphological hallmarks of early stages in cell death are
blebbing, cell shrinkage, nuclear fragmentation, chromatin condensa-
tion or chromosomal DNA fragmentation. The condensation starts
peripherally along the nuclear membrane and during later stages of
death, the nucleus further condenses, and ﬁnally, it breaks up inside a
cell with an intact plasma membrane [53]. This molecular phenomenon
can be evaluated by trypan blue exclusion assay (Gibco, 15,250–061).
In this assay, loss in membrane integrity was determined by the uptake
of the trypan blue dye, to which cells are normally impermeable. For
this analysis, HeLa, MDA-MB-231, K562, and Jurkat cells were diluted
in 1×PBS with a 150,000 cells/mL concentration and injected through
the chip at the ﬂow rate of 2mL/min. All cell types were collected
immediately after their release from the chip to assess the cell viability
after passing through the chip in a biosafety cabinet. The viability was
determined as the number of the live cells over the number of total cells
counted (the live and dead cells) and the relative percentage of the
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control cells at day 0, which were not passing through the chip, was
used to represent cell viability without any treatment. To check for the
metabolic activity of cells, in other words, activation of programmed
cell death, the long-term eﬀect was evaluated by continued culture.
By centrifugation, the cells were isolated from 3% FBS containing
PBS solution, re-suspended in their appropriate medium and continued
being cultured over the course of 3 days for further viability analyses.
Each day, cell images were taken and viability was assessed. For sta-
tistical signiﬁcance, 3 independent experiments (n=3) were per-
formed by injecting diﬀerent cell suspensions through three diﬀerent
replicas of the same chip for each cell line.
2.4. Device characterization/experimental setup
The cell suspensions were pumped into the microchannels by a
50mL plastic syringe using a syringe pump (Harvard Apparatus PHD
2000) with an extended range of ﬂow rates. The experiments were
started with the lowest ﬂow rate which is 400 μL/min, and after getting
video, the ﬂow rate was increased by 100 μL/min. The waiting time at
each ﬂow rate was approximately 90 s. This process is continued until
the last ﬂow rate, which was 2700 μL/min. Each experiment was re-
peated for three times. For the details, see Supp. Info, Text-S4.
3. Results and discussion
An illustration of the chip is provided in Fig. 1. Our goal is to ap-
prehend the eﬀect of curvature angle on cell focusing behavior. Since
the curvature angle has momentous eﬀects on focusing, the geometry of
the microdevice is mainly based on this feature. As the angle of the
curvature increases, the Dean ﬂow becomes stronger. Thus, the strength
of the secondary ﬂow proportionally depends on the curvature angle.
3.1. Diameter of cells
Due to the size variability of mammalian cells, we measured the
sizes of the Jurkat cells, employing to mimic white blood cells (WBCs),
and HeLa, MDA-MB231, K562 cells, which were utilized to mimic CTCs
following ﬂuorescent staining (Fig. 2a). Although both Jurkat and K562
cells are reﬂecting white blood cells with similar size, Jurkat cells are
commonly used for mimicking white blood cells in CTCs research due to
their lymphocytic nature. In addition, a comprehensive analysis of size
and elasticity in various cancer cell lines showed that Jurkat cells are
the most similar cells to leukocytes [54–56]. It is worth mentioning that
the concentration of red blood cells is approximately 107–109 in one mL
of blood, and the preliminary red blood cell lysis process is required to
eliminate the red blood cells before the isolation of CTCs. Although the
concomitant eﬀect of red blood cell lysis process on CTCs is not well
understood [51,57], a number of CTCs isolation techniques [58–61]
have already included this process in their protocols. After processing,
the size distribution of Jurkat cells (mimicking WBCs) in the experi-
ments ranged from 8 μm to 18 μm (Fig. 2b). The determined sizes of
CTCs mimicking cells are as follows: MDA-MB231 cells ranged from
11 μm to 22 μm, K562 cells showed approximately a similar pattern
ranging from 8 μm to 22 μm, and the size of HeLa cells ranged from
16 μm to 29 μm, which is consistent with recent studies [62–64].
3.2. Viability of cancer cells
The viability of the cells before (Day 0) and after (Day 1, 2 and 3)
their release from the microﬂuidic device was analyzed. Morphological
and molecular observations indicate that there was almost no sig-
niﬁcant side eﬀect of relatively high shear forces on the cell viability,
and high viability percentages (> 94%) were achieved (Fig. 3b). Long-
term culture analysis of cells showed suﬃcient recovery of fractions
with accomplished cell proliferation and adhesion even for three days
after their release from the microﬂuidic device (Fig. 3a and c).
3.3. Focusing of cancer cells
To better comprehend how inertial lift and Dean drag forces aﬀect
the cell motion in curvilinear microchannels, we examined cell focusing
in the transition region at various ﬂow rates (400–2500 μL/min). In
parallel lines with our previous study [52], where the focusing behavior
of polystyrene microparticles with the sizes of 20 μm, 15 μm, and 10 μm
was investigated in the same microchannel design, separation potential
was observed only in the transition region. Focusing experiments of
cancer cell lines of Jurkat (8–17 μm), MDA (11–22 μm), K562
(8–22 μm), and HeLa (16–29 μm) were conducted only in the transition
region. Focusing positions and focusing widths of cells are demon-
strated in ReC maps along with representative ﬂuorescent images for a
wide range of Reynolds numbers corresponding to diﬀerent ﬂow rates
(Fig. 4).
In wavy (alternating) curvilinear microchannels, due to sudden
changes in curvature, Dean ﬂow direction continuously changes in the
opposite direction instead of being constant. Because of this con-
tinuously change in Dean ﬂow direction, the exact conditions for the
steady-state position can be hardly deﬁned [65,66]. Before interpreting
the results, it is useful to mention that as we pointed out in the previous
study [52], there are two signiﬁcant facts, which should be taken into
account to better analyze the forces acting on the cells: the Dean drag
force (FD) direction, which depends on the vertical position of the cells,
and the ﬂow velocity maxima shift, which aﬀects the magnitude of the
shear gradient lift force (FS). Considering cells ﬂowing through in a
curvilinear microchannel, the FD direction cannot be determined unless
the cells' vertical position is known since from a cross-sectional per-
spective the direction of FD is from the outer wall to the inner wall when
the cells are close to the top and bottom walls (below the zero Dean
velocity line in the lower half of the channel and above the zero Dean
velocity line in the upper half of the channel), while the direction of FD
is from the inner wall to the outer wall when the cells are near the
vertical center of the channel (above the zero Dean velocity line in the
lower half of the channel and below the zero Dean velocity line in the
upper half of the channel). Another Dean ﬂow eﬀect on the behavior of
the cell can be seen in the main ﬂow velocity proﬁle. Due to the fact
that the velocity proﬁle in straight channels is parabolic, velocity
maxima are located at the centerline. Nevertheless, adding curvature to
the channel geometry not only results in the creation of the FD but also
changes the velocity maxima location.
The direction and presence of the forces acting on cells dramatically
depend on the cell location along the channel. To better understand the
force analysis, here we deﬁned three diﬀerent locations in the channel:
1) upstream of the transition section (Region 1), 2) transition section
where A-A´ line passes (transition section (TR)), and 3) downstream of
the transition section (Region 2) (Fig. 1). According to our ﬁndings,
diﬀerent types of the cells exhibit similar trends (in another words at
least one of the following events are in common for diﬀerent types of
the cells), such as a wide cell focusing band near the centerline at
lowRe, a tighter cell focusing stream near the centerline, a sudden de-
focusing, refocusing near the wall along with the transverse motion,
and a second defocusing (Dean mixing). The transverse motion of rigid
particles passing through the curved channels was also observed by
Gossett et al. [67]. To better explain the physics behind these trends, we
deﬁned three distinct cases (Fig. 5).
At low Re (Re ~ 30), no focusing line can be observed for Jurkat cell
lines. Instead, cells form a wide band near the centerline due to rela-
tively small Dean drag and inertial lift forces (Fig. 4a). Increasing the Re
(Re ~ 83) results in the formation of a thinner focusing line (focusing
width of 35 μm) near the centerline, slightly closer to the W1. This fo-
cusing line migrates towards the centerline when the ﬂow rate is in-
creased as described in Case I. When cells are in Region 1, where the
maxima of the velocity proﬁle are in the half channel near the inner
wall, the cells are pushed from the velocity maxima to the outer wall by
the horizontal component of the FS. In this case, the vertical location of
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the cells is hypothesized to be above and below the zero Dean velocity
line in the upper and lower halves of the microchannel, respectively,
and the direction of the FD is from the outer wall to the inner wall
(Fig. 5a). Thus, the FD balances the FS, where cells go along the cen-
terline. By further moving the cells to the transition section (Section
TR), due to the formation of the velocity maxima at the centerline, the
lift coeﬃcient will be zero, leading to the lack of the FS at this section.
Furthermore, since the direction of the curvature suddenly changes, (as
the inner wall becomes the outer wall and vice versa), the eﬀect of
curvature can be neglected in this section, hence, the FD can be ignored.
In other words, in this section, neither Dean drag force nor inertial
forces are dominant, thus, the cells follow the streamlines until the
velocity maxima are redistributed (Fig. 5b). After passing the transition
section, due to change in the direction of the channel curvature, the
direction of the forces shifts to the opposite direction, whereas the
velocity maxima move towards the inner wall again. At this region
(Region 2), the horizontal component of the FS acts on the cells from
velocity maxima to the outer wall (opposite to the FD) (Fig. 5c).
A sudden defocusing behavior is observed while increasing Re to Re
~ 114 (Fig. 4). Not only horizontal but also vertical components of the
FS decrease because an increase in the ﬂow velocity results in a decrease
in the lift coeﬃcient [68]. As a consequence of crossing the zero Dean
velocity line, cells move towards the vertical center of the channel,
where the direction of FD reverses. Thereupon, both the FS and FD act on
the cells towards the outer wall at Regions 1 and 2, while FS alone
pushes cells towards the W2 at transition section resulting in a defo-
cusing behavior.
Following that, with a further increase in Re, a transverse motion of
focusing cell line is observed (Case III): cells do not migrate along the
essential ﬂow stream but perpendicular to this stream as they move
closer to the W2 at the transition section instead of remaining at the
channel center (Fig. 4). This behavior implies that the cell migration
velocity, UC, is perpendicular to the average ﬂuid velocity, Uf. When
Jurkat cells are in Region 1, where the velocity maxima are in the inner
half of the channel, cells are pushed towards the outer wall by the in-
ﬂuence of both FD and FS (Fig. 5g). When cells arrive to the section TR,
they are already close to the W2 from the previous position. Since the
velocity maxima are near the centerline, a FS acts on cells from velocity
maxima to W2, meanwhile, a wall induced lift force (FW) comes into
play, this time because of the cells' position, and balances the FS re-
sulting in a focusing cell line near the transition section (Fig. 5h). When
the cells reach the Region 2, the directions of both FD and FS change to
Fig. 1. (a) Schematic of the microﬂuidic chip (A ty-
pical PDMS microﬂuidics chip consists of one mi-
crochannel design with one inlet, and three outlets
with a diameter of 1 mm each. The height of the
microchannel is 91 μm, while the width and radius of
curvature are 350 μm and 800 μm, respectively. The
whole chip houses 11 curvilinear geometries, each
having the angle of curvature of 280°. The total chip
length is 9.75mm.), (b) Close up view of the curvi-
linear microchannel with dimensions. (A-A´ cross
section is the transition cross section), and (c) Dean
vortices at the cross-section of the microchannel.
From a cross-sectional view, two vortices track the
lane from the inner wall to the outer wall, parallel to
the z-axis in the middle of the microchannel. Since
these two vortices are counter-rotating, the direction
of the Dean ﬂow is from the outer wall to the inner
wall near the top and bottom walls. Due to the
sudden rotational change, the inner wall becomes
the outer wall and vice versa. Hence, in the transi-
tion section, the walls cannot be deﬁned as outer and
inner walls. The A- and A'-sides of A-A' cross-section
at the transition section were labeled as W1 and W2,
respectively.
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the opposite direction (the inner wall becomes the outer wall and vice
versa) pushing cells towards the centerline, where the shear area is
larger (Fig. 5i). A further increase in ReC to 144 results in a mixing
eﬀect of the cells because FD overcomes FS. The lift coeﬃcient decreases
with the increasing ﬂow velocity [68], and at some point, the FD be-
comes greater than the FS.
Likewise, MDA cell lines initially focus in a wide band (around
130 μm) near the centerline at low Re (Re ~ 30) (Fig. 4) due to rela-
tively small inertial lift and Dean drag forces combined with the low
ﬂow velocity. With an increase in the Re (Re ~ 83), a single cell streak
with a width of almost twice the diameter of a single cell near the
centerline is seen at the transition section, where the streak is slightly
closer to the W1 at the transition section. Comparing the Jurkat and
MDA cells, it can be seen (Fig. 4) that the Jurkat cells move closer to the
W1 than MDA cells at low Re (Re ~ 38). Without a full evaluation, this
behavior of the cells is unexpected at ﬁrst sight, because the FS and FD
change with ap3 and ap, respectively. Therefore, the presumed lateral
position of medium size cells is closer to the centerline than large ones.
By taking the 3D position of the cells and scaling FS with the cells'
vertical position into account, it can be predicted that the large cells are
pushed to the bottom and top walls of the channel, where FD is stronger.
Due to dominance of FD on large cells at the bottom and top walls and
closer position of medium cells to the zero Dean velocity line, FD acting
on the large cells is greater in comparison with that on the medium size
cells so that large cells move closer to the center of the channel than the
medium size cells.
With a further increase in Re (Re>114), the MDA cell stream
slightly migrates towards the W2, before the sudden defocusing (Case
II). When cells are in the Region 1, cells are close to the top and bottom
walls, where the directions of FS and FDare from the inner wall to the
outer wall and from the outer wall the inner wall, respectively (Fig. 5d).
An increase in ﬂow rate results in an increase in both of FS and FD.
However, FS increases more than FD (FS∝Uf2, FD∝Uf1.63) leading to
migration of MDA cell line towards the outer wall in this region. This
migration behavior is not clearly seen in Jurkat cell lines, because the
size of Jurkat cells is smaller than that of MDA cells and not only
horizontal but also vertical component of FS acting on Jurkat cells is
smaller than that on MDA cells at the same ﬂow rate (FS∝ ap3). Hence,
the vertical position of Jurkat cells approaches to the channel center at
lower Reynolds numbers. When cells move to the transition section,
where velocity maxima are near the center of the channel, MDA cells
are not seen at the centerline now. Therefore, unlike Jurkat cells, FS is
present and pushes cells from centerline to the W2. When cells arrive
the Region 2, FD acts on the cells as the counterbalancing force of FS
(Fig. 5e). With a further increase in ﬂow rate, at some point, cells'
vertical position alters towards the center of the channel, where FD acts
in the same direction as FS, leading to a defocusing trend when Re ~129
(Fig. 4). Beyond that, a single cell focusing line is formed near the W2 in
Region 2 along with a transverse motion of the cells along the channel
(Case III), where the particles do not follow the essential ﬂow stream
but instead migrate perpendicular to this stream. Diﬀerent from Jurkat
cells, Dean mixing behavior is not observed in MDA cells. Because of
the larger diameter of the cells, a higher ﬂow rate is required for FD to
become greater than FS (FsJurkat < FsMDA).
No eﬀective single focusing line of K562 cells is observed in this
study, possibly due to a wide range of size distribution of the cells
(8–22 μm). However, after a careful examination of the intense green
areas in Fig. 4, it can be deduced that the behavior of the K562 cells is
very similar to that of MDA cells. The most signiﬁcant factor in cell
behavior is the size. However, the average diameter of both cells is very
close to each other such that K562 and MDA cells have the average
diameter of 16 μm and 17 μm, respectively. With an increase in the Re,
the following observations are present for K562 cells: (1) a wide fo-
cusing band at low Re (Re ~ 38) such that the widest focusing band
among all the cells can be seen here, (2) a tighter focusing band near
the centerline of the channel (Re ~ 76–91) (Case I), Fig. 5a, (3) defo-
cusing of the cell focusing band (Re ~ 98) as a result of transverse
motion of the cells, (4) tighter focusing band near the W2 (Re ~
Fig. 2. (a) Visual images of the cells after staining, and (b) Size distribution of the cells. After processing, the size distribution of Jurkat cells (mimicking WBCs) in the
experiments ranged from 8 μm to 18 μm. The determined sizes of CTCs mimicking cells are as follows: MDA-MB231 cells ranged from 11 μm to 22 μm, K562 cells
showed approximately a similar pattern ranging from 8 μm to 22 μm and the size of HeLa cells ranged from 16 μm to 29 μm, which is consistent with recent studies
[62–64].
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152–174) (Case III), Fig. 5c, and ﬁnally (5) a second defocusing due to
dominant FD (Re ~ 182–189), (Fig. 4).
Due to the larger average diameter of HeLa cells (FS∝ ap3, FD∝ ap),
(among all the cell types employed in this study), the smallest width of
the initial wide focusing band is observed for HeLa cells when Re is 38
(Fig. 4). The behavior of HeLa cells is somewhat similar to that of MDA
cells until Re becomes 129. Beyond that, a sudden defocusing occurs for
MDA cells, whereas the single focusing stream of HeLa cells continues
with its migration to the W2 untilRe ~152 (Case II). In Case II, because
of the larger diameters of HeLa cells, again, not only horizontal but also
vertical component of FS acting on HeLa cells is greater than that on
MDA cells (FS∝ ap3). Therefore, the magnitude of the vertical compo-
nent of the FS is suﬃcient enough to keep HeLa cells below the zero
Dean velocity line in the lower half of the channel and above the zero
Fig. 3. The viability of the cells was analyzed after
their release from the chip, named Day 0. For further
viability assays, cultured cells were examined 24, 48
and 72 h after performing the focusing experiments,
namely Day 1, Day 2 and Day 3, respectively. (a) The
morphological images of Jurkat, K562, MDA, and
HeLa cells at day 0, 1, 2 and 3. (b) Cell viability of
cells at indicated durations. Data are shown as mean
of 3 independent experiments± S.D. (n=3). Cells
could survive for three days after their release with
accomplished cell proliferation and adhesion and
exhibited similar viability rates (> 90%) underlying
the cell viability in all cell lines which were em-
ployed in this study under high shear forces. (c)
Recovery ratio of cell fractions. The ratio was de-
termined as the percentage of live cells before frac-
tionation (at day 0) over the percentage of live cells
after fractionation (at day 1, 2 and 3).
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Dean velocity line in the upper half of the channel, while it is not
adequate for MDA cells to keep them close to the channel top and
bottom walls at Re ~ 152.
In Region 1, the direction of FS is from velocity maxima to the outer
wall, whereas the direction of FD is from the outer wall to the inner wall
(Fig. 5d). Because of the fact that FS and FD scale with Uf2 and Uf1.63,
respectively, a greater FS compared to FD causes a migration of single
cell focusing stream towards the outer wall. In the transition section,
since cells are not at the centerline anymore, FS is present and it is the
only major force acting on the HeLa cells. However, the focusing stream
is not disturbed, probably because of the momentum of the cells. At ﬁrst
glance, it may be confusing that the FS is present in Case II and not in
Case I at the transition section. The reason behind this is that the lo-
cation of the cells in Case I is not the same as in Case II. When Re is 159,
Fig. 4. Re maps at the transition section: (a) Jurkat (magenta), (b) MDA cell line (red), (c) K562 cell line (green), (d) HeLa (blue) cell lines (left column). Cell line
streams for diﬀerent Reynolds numbers corresponding to ﬁve selected ﬂow rates between 500 and 2500 μL/min (i–v) (right columns). The A- and A'-sides of A-A'
cross-section at the transition section were labeled as W1 and W2, respectively. The top and bottom of each map are represented as W1 and W2, respectively.
Fig. 5. Forces acting on the cells: Case I) when the cells go along the channel near the centerline before defocusing, Case II) when the cells migrate towards the W2
before defocusing, and Case III) transverse motion and refocusing near the W2 at the transition section after defocusing. (Estimated approximate cells positions from a
cross-section view of the channel and forces acting on the cells for each case as well as each region and transition section are displayed.) The velocity maxima form
near the inner half of the channel in Region 1 and shift to the channel centerline at the transition section (Section TR). Although the inner wall becomes the outer wall
beyond the transition section, the velocity maxima again shift to the inner half of the channel in Region 2. Continuously shifting the velocity maxima in the transition
sections results in a diﬀerential change not only in the horizontal component but also in the vertical component of the FS. Therefore, the 3D position of the cells
continuously changes. This eﬀect ampliﬁes with decreasing cell size because FS scales with ap3, hence, the vertical component of the FS will be still suﬃcient enough
for pushing the larger cells above the zero Dean velocity line while smaller cells approach to the vertical center of the channel due to a weaker vertical component of
FS and experience a change in the FD direction. It is worth mentioning that the direction of the FS is from the velocity maxima to the channel walls. The A- and A'-sides
of A-A' cross-section at the transition section were labeled as W1 and W2, respectively.
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the HeLa cells are defocused and increasing the ReC further (Re>174)
results in refocusing of cells near the W2 (Case III). Defocusing occurs at
higher Re for these cells compared to the other ones (Re ~ 159) because
of larger average diameter. In case III, after defocusing, cells approach
to the outer wall in the region I under the inﬂuence of the combined
eﬀect of Dean drag and inertial lift forces (Fig. 5g). Since the cells are
already close to the outer wall in the region I, when they arrive the
transition section, they are also close to the W2. Hence, FS balances FW
in the section TR (Fig. 5h).
3.4. Comparison between the cells and the particles with 15 and 20 μm
diameter
Particle dynamics of polystyrene microparticles with the diameter
of 10, 15 and 20 μm was analyzed using the same microchannel con-
ﬁguration in our previous study [52]. To have a better understanding
about inertial microﬂuidics, a comparison of focusing positions of rigid
(polystyrene) and elastic (cells) particles is presented in Fig. 6 based on
the experimental data of our previous study [52]. Owing to the fact that
particles/cells behavior highly depends on the size in inertial micro-
ﬂuidics, our priority on interpreting the results relies on the size
proximity between the type of cells and the polystyrene particles.
However, due to the fact that no single focusing position of 10 μm
particles is observed in our previous study [52], comparison of 10 μm
particles with cancer cell lines is found to be unnecessary.
The size distribution of the Jurkat cells is between 8 and 17 μm, and
their average diameter is 12 μm. Since the average diameter of these
cells is close to 15 μm rather than 20 μm, the focusing trend of Jurkat
cells is more similar to the 15 μm particles (compared to 20 μm parti-
cles) as can be seen in Figs. 6a and b. However, the sudden defocusing
occurs when Re is 114, while it is observed at Re ~ 136 for the 15 μm
particles. Additionally, the Dean mixing eﬀect on Jurkat cells is
stronger than that on 15 μm particles. It is likely because the average
diameter of Jurkat cells is smaller than 15 μm.
Likewise, because the average diameter of HeLa cells (21 μm) is
closer to the 20 μm rather than 15 μm, and the size distribution of these
cells is in between 16 μm to 21 μm, the focusing trend of the HeLa cells
is similar to the 20 μm particles (Fig. 6d). However, the initial wide
focusing band of Hela cells is found to be closer to W1 compared to the
20 μm particles at lowRe. While the sudden defocusing is not observed
for 20 μm particles, the focusing stream of the HeLa cells is disturbed
when Re is 152.
Since the average diameter of the MDA cells (17 μm) is between
15 μm and 20 μm, the focusing behavior of these cells is seen to be a
combination of the 15 μm and 20 μm particles' behavior (Figs. 6e and f).
The sudden defocusing observed for 15 μm particles is also seen in the
MDA cells. However, Dean mixing is not observed similar to the 20 μm
particles. Instead, MDA cells focus near the W2 at higherRe.
Comparing the behavior of the K562 cells with the 15 and 20 μm
particles is rather diﬃcult because a single cell focusing line cannot be
observed for K562 cells. It is likely because of the wide range of cell
diameter, which is between 8 and 22 μm. Somehow, events like sudden
Fig. 6. A comparison between the rigid microparticles (white) and the employed cells, Jurkat cells (magenta), HeLa cells (blue), MDA cells (red), K562 cells (green).
(For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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defocusing, focusing near the W2, and Dean mixing are in common with
the 15 μm particles.
In addition to shear gradient lift, wall induced lift, and Dean drag
forces, the deformability of bio-particles/cells can lead to additional lift
forces. Hur et al. studied diﬀerent particles with diﬀerent shapes and
reported that focusing positions of particles were not aﬀected by the
shape of the particles [69]. In contrast to a rigid particle, a deformable
particle may have a net lift force leading to particles' lateral migration.
Hur et al. and Masaeli et al. showed that above a critical Reynolds
number (Re ~ 50), particles predominantly adopted preferred equili-
brium positions and “tumbling” rotational axis [69,70]. This rotational
axis focusing position was found to be independent of cross-sectional
shape and mainly dependent on the rotational diameter. During the
tumbling motion, when the major axis rotates perpendicular to the
wall, the wall induced lift increases substantially due to the closer
distance. As a result, the combined force on the particle/cell is higher
than that on a sphere of the same volume. Hur et al. experimentally
demonstrated that the direction of deformability-induced lift force is
towards the center (in Poiseuille ﬂow) [71]. As the deformability in-
duced lift force increases, cells shift towards the channel center in
straight channels. This eﬀect is not clearly detected in our study. In fact,
comparing the behavior of cells with rigid particles from the theoretical
point of view is challenging since the standard deviation of the size
range of commercially available particles is rather small compared to
that of the cells.
3.5. Focusing positions
The overlaid ﬂuorescent images and the focusing positions graphs
are illustrated in Fig. 7. The results indicate that separation of K562
cells from Jurkat cells is not possible, because no eﬀective single cell
focusing line of K562 cells is achieved (Fig. 4). The optimum separation
potential is achieved for the Jurkat and MDA cells when Re is 121 at the
transition section in the symmetric curvilinear channel (with the cur-
vature angle of 280°) (Fig. 7a), since MDA cells move near the center-
line, while most of Jurkat cells travel near the W2. One of the main
reasons for diﬀerent focusing stream locations of these two cells is that
the dimensions of the cells are diﬀerent, and therefore, the directions of
the forces acting on the cells are diﬀerent because of the diﬀerent
vertical positions of the cells. The corresponding distance between the
focusing streams of Jurkat and MDA cells is approximately 95 μm. In
the same manner, the optimal Reynolds number is found to be 121 for
the HeLa and Jurkat cells with a focusing cell stream distance of ap-
proximately 105 μm.
4. Conclusions
A continuous, high-throughput and parallelizable size-based par-
ticle focusing technique was developed in a speciﬁc symmetrical curved
channel by taking the advantage of inertial microﬂuidics and Dean ﬂow
physics. The inertial focusing behavior of cancer cell lines MDA-MB-231
(11–22 μm), Jurkat (8–17 μm), K562 (8–22 μm), and HeLa (16–29 μm)
in a curvilinear channel with a curvature angle of 280° was investigated
in this study.
Our simulation results show that the velocity maxima shift from the
inner wall to the centerline and from the centerline to the inner wall
again along the channel in the transition section under the inﬂuence of
Dean ﬂow. Hence, the lateral position of cells is signiﬁcant when con-
sidering the force balance. This study also underlines the signiﬁcance of
the recognition that not only lateral but also vertical positions of cells
depend on the ﬂow velocity as well as the cell size, which dramatically
alters the force balance on the cells. Comparing bioparticles (cells) with
rigid particles, it is foreseen that further comprehensive studies on si-
mulation of the behavior of particles or cells by considering the elas-
ticity or stiﬀness eﬀect at diﬀerent ﬂow rates as well as on the eﬀect of
size range of particle/cell on their focusing behavior will elicit the
reason behind diﬀerent focusing characteristics.
Our results indicate that separations of the MDA and Jurkat cells
(Jurkat cells were used to mimic white blood cells) as well as the HeLa
and Jurkat cells can be possible at the transition section of the sym-
metric curvilinear channels (with curvature angle of 280°) at Re ~ 121
since the maximum distances between the Jurkat and MDA cells and
Jurkat and HeLa cells were measured as 95 μm and 105 μm, respec-
tively, at this Reynolds number. Additionally, this design is compatible
with high throughput designs since many parallel channels could be
placed in a rather small footprint area. Based on the results of this
study, it can be deduced that the isolation of CTCs from vasculature
system can be achieved, although further studies should be performed
by using patient samples in order to put the current design in clinical
context. Because of promising results, we believe that the character-
ization of rare cells in future studies will lead to better prognosis using
CTC isolation from blood.
Fig. 7. Focusing positions of the cancer cell lines at
the transition region in the curvilinear channel with
a curvature angle of 280° for diﬀerent ﬂow rates (left
column), cell streams for optimum Reynolds number
(right column) for: a) Jurkat (magenta) and MDA
(red), b) Jurkat (magenta), and HeLa (blue) cell
lines. Error bars indicate the focusing width. Jurkat
cell lines were used to mimic white blood cells, and
K562, MDA-MB-231, and HeLa cells were used to
mimic circulating tumor cells. (The optimum condi-
tions for cells (between Jurkat and CTCs) were de-
termined based on the measurements of the distance
between the cell streams at the given Reynolds
number.) (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to
the web version of this article.)
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